CLINICAL_TRIALS
trial_result
· 2023-11-29
Clinical Trial Update: Study of Cilofexor in Adults With Primary Sclerosing Cholangitis [Phase 3]
Summary
A Phase 3 trial of cilofexor in adults with primary sclerosing cholangitis was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Primary Sclerosing Cholangitis | Phase 3 | Status: TERMINATED | Results posted: 2023-11-29